Seeing Is Believing
Currently out of the existing stock ratings of Scott Schoenhaus, 167 are a BUY (88.83%), 20 are a HOLD (10.64%), 1 are a SELL (0.53%).
Analyst Scott Schoenhaus, currently employed at KEYBANK, carries an average stock price target met ratio of 53.9% that have a potential upside of 27.4% achieved within 145 days.
Scott Schoenhaus’s has documented 357 price targets and ratings displayed on 26 stocks. The coverage is on Healthcare, Technology, Consumer Cyclical sectors.
Most recent stock forecast was given on OMCL, Omnicell at 31-Jul-2026.
Analyst best performing recommendations are on LVGO (LIVONGO HEALTH).
The best stock recommendation documented was for LVGO (LIVONGO HEALTH) at 7/6/2020. The price target of $95 was fulfilled within 2 days with a profit of $17.37 (22.38%) receiving and performance score of 111.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 21-Oct-2025
$7.5
$1.98 (35.87%)
$7
2 months ago
(03-Aug-2026)
13/26 (50%)
$0.82 (12.28%)
71
Hold Since 22-Dec-2020
$7.5
$1.98 (35.87%)
$6
2 months 3 days ago
(30-Jul-2026)
14/16 (87.5%)
$0.92 (13.98%)
32
Buy Since 04-Jan-2017
$10
$4.48 (81.16%)
$11
2 months 3 days ago
(30-Jul-2026)
23/40 (57.5%)
$3.42 (51.98%)
210
Buy Since 07-Jul-2026
$10.5
$4.98 (90.22%)
$7
2 months 26 days ago
(07-Jul-2026)
16/25 (64%)
$0.98 (10.29%)
47
Hold Since 21-Apr-2025
$7
$-1.39 (-16.57%)
$8
6 months 7 days ago
(26-Mar-2026)
13/16 (81.25%)
$1.48 (26.81%)
60
Which stock is Scott Schoenhaus most bullish on?
Which stock is Scott Schoenhaus most reserved on?
What Year was the first public recommendation made by Scott Schoenhaus?